中国普外基础与临床杂志

中国普外基础与临床杂志

直肠癌术前放化疗反应的相关因素分析

查看全文

目的分析与进展期直肠癌术前放化疗反应相关的临床因素。 方法回顾性分析我院2005年1月至2012年12月期间107例接受术前放化疗后行根治性手术的直肠癌患者的临床资料,分析对直肠癌术前放化疗反应的影响因素。 结果单因素分析结果显示,年龄、性别、肿瘤距肛缘距离、肿瘤分化程度、肿瘤浸润深度、治疗前CA19-9水平与直肠癌患者对术前放化疗反应无关(P>0.05),而肿瘤周径、肿瘤活动度、淋巴结转移、治疗前癌胚抗原(CEA)和血红蛋白水平与直肠癌患者对术前放化疗反应有关(P<0.05)。进一步logistic回归分析结果显示,肿瘤活动度(P=0.015)、治疗前CEA水平(P=0.012)和治疗前血红蛋白水平(P=0.007)是影响直肠癌患者对术前放化疗反应的独立危险因素,即直肠癌固定、治疗前CEA水平>5.0μg/L及治疗前血红蛋白水平≤10 g/L的直肠癌患者对术前放化疗反应差。 结论通过对直肠癌术前放化疗影响因素的分析,可预测对放化疗的反应,指导临床进行个体化治疗及相关临床干预。

ObjectiveTo analyze the clinical predictive factors of tumor pathological response to preoperative chemoradiotherapy for rectal cancer. MethodsOne hundred and seven patients treated with preoperative capecitabine and pelvic conformal radiotherapy and underwent total mesorectal excision from January 2005 to December 2012 in this hospital were analyzed retrospectively.Tumor response according to tumor regression grade was evaluated.The correlation of clinicopathologic factors with tumor response was analyzed by logistic regression analysis. ResultsThe single factor analysis results showed that the age, gender, distance of tumor from anal verge, differentiation degree of tumor, infiltration depth of tumor, and pretreatment CA19-9 level were not correlated with rectal cancer pathological response to preoperative chemoradiotherapy (P > 0.05).The tumor circumferential extent, tumor mobilit, lymph node metastasis, pretreatment carcinoembryonic antigen (CEA) level, and pretreatment hemoglobin level were correlated with it (P < 0.05).The logistic regression analysis results showed that non-fixed tumor (P=0.015), pretreatment CEA level≤5.0μg/L (P=0.012), and pretreatment hemoglobin level > 10 g/L (P=0.007) independently predicted a good pathologic response rate. ConclusionTumor mobility, pretreatment CEA level, and hemoglobin level are important predictors of pathological response to preoperative chemoradiotherapy in rectal cancer.

关键词: 直肠癌; 术前放化疗; 肿瘤消退

Key words: Rectal cancer; Chemoradiotherapy; Tumor regression

引用本文: 陈纲, 李世拥, 于波, 崔伟, 袁强. 直肠癌术前放化疗反应的相关因素分析. 中国普外基础与临床杂志, 2014, 21(2): 177-181. doi: 10.7507/1007-9424.20140041 复制

登录后 ,请手动点击刷新查看全文内容。 没有账号,
登录后 ,请手动点击刷新查看图表内容。 没有账号,
1. Scott NA, Susnerwala S, Gollins S, et al.Preoperative neo-adju-vant therapy for curable rectal cancer-reaching a consensus 2008[J].Colorectal Dis, 2009, 11(3):245-248.
2. Sauer R, Liersch T, Merkel S, et al.Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer:results of the German CAO/ARO/AIO-94 randomized phaseⅢtrial after a median follow-up of 11 years[J].J Clin Oncol, 2012, 30(16):1926-1933.
3. Kuremsky JG, Tepper JE, McLeod HL.Biomarkers for response to neoadjuvant chemoradiation for rectal cancer[J].Int J Radiat Oncol Biol Phys, 2009, 74(3):673-688.
4. 崔伟, 陈纲, 左富义, 等.末端回肠双腔造口与横结肠双腔造口的对比研究[J].中国普通外科杂志, 2011, 20(10):1098-1100.
5. Mandard AM, Dalibard F, Mandard JC, et al.Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma.Clinicopathologic correlations[J].Cancer, 1994, 73(11):2680-2686.
6. Korkeila EA, Syrjanen K, Bendardaf R, et al.Preoperative radiotherapy modulates ezrin expression and its value as a predictive marker in patients with rectal cancer[J].Hum Pathol, 2011, 42(3):384-392.
7. Shinto E, Hashiquchi Y, Ueno H, et al.Pretreatment C D133 and cyclooxygenase-2 expression as the predictive markers of the pathological effect of chemoradiotherapy in rectal cancer patients[J].Dis Colon Rectum, 2011, 54(9):1006-1098.
8. Hu-Lieskovan S, Vallbohmer D, Zhang W, et al.EGF61 polymor-phism predicts complete pathologic response to cetuximabbased chemoradiation independent of KRAS status in locally advanced rectal cancer patients[J].Clin Cancer Res, 2011, 17(15):5161-5169.
9. Yoon SM, Kim DY, Kim TH, et al.Clinical parameters predicting pathologic tumor response after preoperative chemoradiotherapy for rectal cancer[J].Int J Radiat Oncol Biol Phys, 2007, 69(4):1167-1172.
10. Park YA, Sohn SK, Seong J, et al.Serum CEA as a predictor for the response to preoperative chemoradiation in rectal cancer[J].J Surg Oncol, 2006, 93(2):145-150.
11. Yoon WS, Park W, Choi DH, et al.Importance of the circumferential extent of tumors and clinical lymph node status as prognostic factors after preoperative chemoradiotherapy and surgery in patients with rectal cancer[J].Tumori, 2010, 96(4):568-576.
12. Suárez J, Vera R, Balén E, et al.Pathologic response assessed by Mandard grade is a better prognostic factor than down staging for disease-free survival after preoperative radiochemotherapy for advanced rectal cancer[J].Colorectal Dis, 2008, 10(6):563-568.
13. Ryu YJ, Kim CH, Kim HJ, et al.Clinical significance of serial serum carcinoembryonic antigen values for treating rectal cancer with preoperative chemoradiotherapy[J].J Korean Soc Coloproctol, 2012, 28(4):205-212.
14. Ishihara S, Watanabe T, Kiyomatsu T, et al.Prognostic signifi-cance of response to preoperative radiotherapy, lymph node metas-tasis, and CEA level in patients undergoing total mesorectal excision of rectal cancer[J].Int J Colorectal Dis, 2010, 25(12):1417-1425.
15. 吴文铭, 邱辉忠, 吴斌, 等.临床病理指标预测直肠癌新辅助治疗效果初探[J].中华外科杂志, 2010, 48(5):348-352.
16. Lee JH, Kim SH, Jang HS, et al.Preoperative elevation of carci-noembryonic antigen predicts poor tumor response and frequent distant recurrence for patients with rectal cancer who receive preoperative chemoradiotherapy and total mesorectal excision:a multi-institutional analysis in an Asian population[J].Int J Colorectal Dis, 2013, 28(4):511-517.
17. Das P, Skibber JM, Rodriguez-Bigas MA, et al.Predictors of tumor response and downstaging in patients who receive preoper-ative chemoradiation for rectal cancer[J].Cancer, 2007, 109(9):1750-1755.
18. Yasuda H.Solid tumor physiology and hypoxia-induced chemo/radio-resistance:novel strategy for cancer therapy:nitric oxide donor as a therapeutic enhancer[J].Nitric Oxide, 2008, 19(2):205-216.
19. Lee SD, Park JW, Park KS, et al.Influence of anemia on tumor response to preoperative chemoradiotherapy for locally advanced rectal cancer[J].Int J Colorectal Dis, 2009, 24(12):1451-1458.